Cargando…
Naldemedine-induced Opioid Withdrawal Syndrome in a Patient with Breast Cancer without Brain Metastasis
Opioid-induced-constipation (OIC) can be treated by naldemedine and other peripherally acting mu-opioid receptor antagonists (PAMORA) via a novel mechanism. We describe the case of a 52-year-old female outpatient who developed OIC while receiving oxycodone for pain due to cancer with multiple bone m...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008055/ https://www.ncbi.nlm.nih.gov/pubmed/31534081 http://dx.doi.org/10.2169/internalmedicine.3098-19 |
_version_ | 1783495409553899520 |
---|---|
author | Ishii, Koji Yamashita, Haruna Yamaguchi, Midori Komatsu, Yuya Ryu, Emi Morishita, Satoru Matsuo, Kumi Kamada, Masatsugu Ikeda, Tsunako Ashizawa, Kazuto Hara, Tetsuya |
author_facet | Ishii, Koji Yamashita, Haruna Yamaguchi, Midori Komatsu, Yuya Ryu, Emi Morishita, Satoru Matsuo, Kumi Kamada, Masatsugu Ikeda, Tsunako Ashizawa, Kazuto Hara, Tetsuya |
author_sort | Ishii, Koji |
collection | PubMed |
description | Opioid-induced-constipation (OIC) can be treated by naldemedine and other peripherally acting mu-opioid receptor antagonists (PAMORA) via a novel mechanism. We describe the case of a 52-year-old female outpatient who developed OIC while receiving oxycodone for pain due to cancer with multiple bone metastases. Although she did not have brain metastasis, opioid withdrawal syndrome (OWS) developed after taking naldemedine orally. Her Clinical Opiate-Withdrawal Score (COWS) was 19 (moderate symptoms). However, she recovered from OWS on intravenous fentanyl and a continuous infusion of oxycodone. She did not develop OWS thereafter and was discharged two days after recovery. |
format | Online Article Text |
id | pubmed-7008055 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | The Japanese Society of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-70080552020-02-10 Naldemedine-induced Opioid Withdrawal Syndrome in a Patient with Breast Cancer without Brain Metastasis Ishii, Koji Yamashita, Haruna Yamaguchi, Midori Komatsu, Yuya Ryu, Emi Morishita, Satoru Matsuo, Kumi Kamada, Masatsugu Ikeda, Tsunako Ashizawa, Kazuto Hara, Tetsuya Intern Med Case Report Opioid-induced-constipation (OIC) can be treated by naldemedine and other peripherally acting mu-opioid receptor antagonists (PAMORA) via a novel mechanism. We describe the case of a 52-year-old female outpatient who developed OIC while receiving oxycodone for pain due to cancer with multiple bone metastases. Although she did not have brain metastasis, opioid withdrawal syndrome (OWS) developed after taking naldemedine orally. Her Clinical Opiate-Withdrawal Score (COWS) was 19 (moderate symptoms). However, she recovered from OWS on intravenous fentanyl and a continuous infusion of oxycodone. She did not develop OWS thereafter and was discharged two days after recovery. The Japanese Society of Internal Medicine 2019-09-18 2020-01-15 /pmc/articles/PMC7008055/ /pubmed/31534081 http://dx.doi.org/10.2169/internalmedicine.3098-19 Text en Copyright © 2020 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Ishii, Koji Yamashita, Haruna Yamaguchi, Midori Komatsu, Yuya Ryu, Emi Morishita, Satoru Matsuo, Kumi Kamada, Masatsugu Ikeda, Tsunako Ashizawa, Kazuto Hara, Tetsuya Naldemedine-induced Opioid Withdrawal Syndrome in a Patient with Breast Cancer without Brain Metastasis |
title | Naldemedine-induced Opioid Withdrawal Syndrome in a Patient with Breast Cancer without Brain Metastasis |
title_full | Naldemedine-induced Opioid Withdrawal Syndrome in a Patient with Breast Cancer without Brain Metastasis |
title_fullStr | Naldemedine-induced Opioid Withdrawal Syndrome in a Patient with Breast Cancer without Brain Metastasis |
title_full_unstemmed | Naldemedine-induced Opioid Withdrawal Syndrome in a Patient with Breast Cancer without Brain Metastasis |
title_short | Naldemedine-induced Opioid Withdrawal Syndrome in a Patient with Breast Cancer without Brain Metastasis |
title_sort | naldemedine-induced opioid withdrawal syndrome in a patient with breast cancer without brain metastasis |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008055/ https://www.ncbi.nlm.nih.gov/pubmed/31534081 http://dx.doi.org/10.2169/internalmedicine.3098-19 |
work_keys_str_mv | AT ishiikoji naldemedineinducedopioidwithdrawalsyndromeinapatientwithbreastcancerwithoutbrainmetastasis AT yamashitaharuna naldemedineinducedopioidwithdrawalsyndromeinapatientwithbreastcancerwithoutbrainmetastasis AT yamaguchimidori naldemedineinducedopioidwithdrawalsyndromeinapatientwithbreastcancerwithoutbrainmetastasis AT komatsuyuya naldemedineinducedopioidwithdrawalsyndromeinapatientwithbreastcancerwithoutbrainmetastasis AT ryuemi naldemedineinducedopioidwithdrawalsyndromeinapatientwithbreastcancerwithoutbrainmetastasis AT morishitasatoru naldemedineinducedopioidwithdrawalsyndromeinapatientwithbreastcancerwithoutbrainmetastasis AT matsuokumi naldemedineinducedopioidwithdrawalsyndromeinapatientwithbreastcancerwithoutbrainmetastasis AT kamadamasatsugu naldemedineinducedopioidwithdrawalsyndromeinapatientwithbreastcancerwithoutbrainmetastasis AT ikedatsunako naldemedineinducedopioidwithdrawalsyndromeinapatientwithbreastcancerwithoutbrainmetastasis AT ashizawakazuto naldemedineinducedopioidwithdrawalsyndromeinapatientwithbreastcancerwithoutbrainmetastasis AT haratetsuya naldemedineinducedopioidwithdrawalsyndromeinapatientwithbreastcancerwithoutbrainmetastasis |